Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems Eversense 365 and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. Its CGM systems are indicated for continually measuring glucose levels for up to 365 days for Eversense 365 and 180 days for Eversense E3 in persons with diabetes age 18 and older. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device.
Símbolo de cotizaciónSENS
Nombre de la empresaSenseonics Holdings Inc
Fecha de salida a bolsaMar 04, 2015
Director ejecutivoGoodnow (Timothy T)
Número de empleados117
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 04
Dirección20451 Seneca Meadows Pkwy
CiudadGERMANTOWN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal20876-7005
Teléfono13015157260
Sitio Webhttps://www.senseonics.com/
Símbolo de cotizaciónSENS
Fecha de salida a bolsaMar 04, 2015
Director ejecutivoGoodnow (Timothy T)
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos